Instituto de Investigación Sanitaria de Santiago

• Jesus Perez Camiña

  Lead investigator

Sources: openalex.org

• Instituto de Salud Carlos III

  Recuperación funcional del músculo esquelético a través de la activación del sistema obestatina/GPR39: valoración del alcance terapéutico en entidades clínicas asociadas a la atrofia muscular, PI18/00760, €183.9k, 2019–2021, Jan 1, 2019

Sources: openalex.org

• Extreme Longevity Areas: Redefining the Need for A Transparent and Standardized Framework

  Aging and disease, Sep 30, 2026

• Cardiovascular risk factors and their evolution in a primary care psoriasis cohort: The REPICA study

  Semergen, Sep 29, 2026

• Clinical Outcomes According to Age and Atrial Fibrillation Type: Insights from the Multicentre REGUEIFA Registry

  Journal of clinical medicine, Sep 28, 2026

• A novel target associated with senescence and inflammatory signaling in human intervertebral disc degeneration

  bioRxiv, Sep 3, 2026

• Cardiovascular and renal protection of SGLT2i in early-stage type 2 diabetes: the DIAB-CV-AP study

  Nutrition, metabolism, and cardiovascular diseases : NMCD, Aug 21, 2026

• Circulating MMP-7 is associated with cognitive decline in individuals with vascular risk factors

  Journal of Alzheimer's disease : JAD, Aug 9, 2026

• Is population-based cardiovascular screening feasible in primary care? Results from the PreveCardio program

  Revista espanola de cardiologia (English ed.), Aug 6, 2026

• Discovery of Novel Synthetic Cyclohexene-Based Small Molecules Targeting Senescence against Age-Related Pulmonary Fibrosis

  Journal of medicinal chemistry, Jul 10, 2026

• Aging ADNP syndrome mice exhibit mutation/sex-dependent disruption of motor behavior and circadian rhythmicity

  Neurobiology of disease, Jun 27, 2026

• Brain endothelial Gαq/11 signalling in cerebrovascular function and cognition of aged mice

  EBioMedicine, May 19, 2026

• Do subjective cognitive complaints and slow gait speed increase the probability of progression to objective cognitive impairment? A systematic review and meta-analysis on motoric cognitive risk syndrome

  GeroScience, Apr 21, 2026

• Cellular reprogramming beyond pluripotency

  Trends in molecular medicine, Mar 22, 2026

• Deletion of Mfn2 in endothelial cells triggers a mitohormetic response that improves systemic metabolism and healthspan in mice

  Cell metabolism, Feb 19, 2026

• Life expectancy and causes of death in classical laminopathic progeroid syndromes: systematic review with individual-patient data synthesis

  Aging, Feb 12, 2026

• LEAP2 acts in hepatocytes and at central level, alleviates steatosis and inflammation but resistance in obese and aging

  Life sciences, Jan 23, 2026

• Moderating effect of the domains of the cognitive reserve index questionnaire (CRIq) on longitudinal change slopes in episodic memory across the cognitive aging continuum

  Scientific reports, Jan 20, 2026

• Plasma p ‐tau changes across the clinical spectrum of Alzheimer's disease: a systematic review and meta‐analysis

  AAIC 2025 abstract, Jan 8, 2026

• Predicting cognitive worsening using subjective reports of dyads and biological biomarkers in pre‐clinical stages: Preliminary results from the CompAS cohort study

  AAIC 2025 abstract, Jan 7, 2026

• Plasma Aβ40, Aβ42, Aβ42/40 ratio, tau, p ‐tau181, p ‐tau217 and NfL biomarkers to discriminate the prodromal stage of dementia along the continuum of cognitive impairment: Sex differences in the CompAS study

  AAIC 2025 abstract, Jan 7, 2026

• Cellular senescence meets infection: highlights from the 10th annual International Cell Senescence Association (ICSA) conference, Rome 2025

  Aging, Dec 29, 2025